Heyholder
‹ Activism Filings

Penetrium Bioscience Inc. Q3 revenue KRW 1.9 billion, operating loss KRW 2.7 billion

Penetrium Bioscience Inc.· Periodic Report

AI summary · Not investment advice

Penitrium Bio sold KRW 1.9 billion worth in Q3 and lost KRW 2.7 billion from its main business, versus a KRW 1.5 billion loss a year earlier.

Operating profit · 3 months

KRW -2.7 billion

Key facts

Revenue (3 months)
KRW 1.9 billion
Net income (3 months)
KRW -2.7 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 2.6 billion
Revenue (year to date)
KRW 5.7 billion
Operating profit (prior-year 3 months)
KRW -1.5 billion
Operating profit (year to date)
KRW -6.4 billion
Net income (prior-year 3 months)
KRW -8.5 billion
Net income (year to date)
KRW -6.1 billion

Commentary

AI commentary · Not investment advice

What happened

Penitrium Bio reported its third-quarter results on a standalone basis. Sales for the three months were KRW 1.89 billion. That is 27.4% lower than the same period a year earlier. It is also 10.6% lower than the previous quarter. Cumulative sales this year are KRW 5.70 billion.

In the company's terms

Operating profit (profit from the core business) for the three months was a loss of KRW 2.67 billion. A year earlier, the same period showed an operating loss of KRW 1.46 billion. The cumulative operating loss this year is KRW 6.37 billion.

What changes for shareholders

Net income (the final profit after taxes and all other items) for the three months was a loss of KRW 2.74 billion. A year earlier, the same period showed a net loss of KRW 8.46 billion. The cumulative net loss this year is KRW 6.11 billion.

Comments

No comments yet

Comments from shareholders will appear here.